Brainstorm Cell Therapeutics Inc. (BCLI)
Company Info
| ISIN | US10501E2019 |
|---|---|
| CUSIP | 10501E201 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $2.97 |
|---|---|
| Year Range | $2.55 - $4.23 |
| EMA (50) | $2.78 |
| EMA (200) | $3.07 |
| Average Volume | $54.82K |
| Market Capitalization | $108.36M |
BCLIShare Price Chart
Click Calculate to get results
BCLIPerformance
The chart shows the growth of $10,000 invested in Brainstorm Cell Therapeutics Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $7,615 for a total return of roughly -23.85%. All prices are adjusted for splits and dividends.
BCLIReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 10.00% | 8.19% |
| 6M | -2.62% | -7.42% |
| YTD | -25.75% | -13.03% |
| 1Y | -21.22% | -5.85% |
| 5Y | -7.23% | 10.86% |
| 10Y | -2.58% | 11.53% |
BCLIMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -22.00% | -2.24% | 10.16% | -10.71% | -2.00% | -6.12% | -7.25% | 16.02% | ||||
| 2021 | 33.48% | -32.78% | -5.67% | -9.40% | 3.17% | 6.15% | 6.05% | -13.90% | -4.90% | -12.27% | 31.26% | 5.26% |
| 2020 | -4.91% | 71.50% | -33.52% | 32.54% | 21.14% | 50.47% | 20.87% | -6.94% | 34.18% | -40.72% | -44.92% | -18.10% |
| 2019 | 3.38% | 6.54% | 11.00% | -8.29% | -8.04% | 7.92% | 1.52% | -7.23% | 4.84% | -6.92% | 9.37% | 7.81% |
| 2018 | -11.22% | -11.78% | 2.61% | 4.13% | 52.44% | -22.00% | 5.90% | -4.12% | -3.54% | -14.79% | -4.45% | 14.15% |
| 2017 | 11.81% | 53.17% | -2.30% | -2.82% | -4.36% | 5.06% | 12.29% | -8.58% | -3.29% | 3.64% | -4.68% | -3.69% |
| 2016 | -13.64% | -6.07% | 15.09% | -16.10% | -0.89% | 8.56% | 5.81% | -6.27% | 0.84% | -3.73% | -7.33% | 18.14% |
| 2015 | -16.18% | 6.52% | 4.71% | -17.98% | 4.38% | -5.25% | -10.80% | -5.59% | -24.67% | 21.40% | -1.44% | 4.38% |
| 2014 | 41.67% | 8.82% | -0.90% | 5.45% | -5.83% | 33.28% | -12.23% | -1.56% | -12.88% | -11.68% | -14.88% | 54.05% |
| 2013 | 3.99% | 3.49% | 2.08% | -4.90% | -9.87% | -0.19% | 14.03% | -18.41% | -0.77% | -3.10% | -7.20% | 3.45% |
| 2012 | 12.20% | 4.35% | -8.33% | 6.82% | 6.38% | 10.80% | -5.42% | -10.69% | -3.85% | 0.00% | -13.33% | 14.36% |
| 2011 | 36.84% | 42.31% | -18.92% | -5.00% | -1.75% | 75.71% | -9.55% | -10.11% | -21.25% | -11.43% | -5.02% | -22.64% |
| 2010 | -3.85% | 32.00% | 1.52% | -19.40% | -3.70% | -23.08% | 20.00% | -12.50% | 4.76% | -9.09% | 2.50% | -7.32% |
BCLIDividend History
Brainstorm Cell Therapeutics Inc. doesn't pay dividends
BCLIDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
BCLIWorst Drawdowns
The table below shows the maximum drawdowns of the Brainstorm Cell Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Brainstorm Cell Therapeutics Inc. is 85.62%, recorded on Jul 26, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -85.62% | Oct 9, 2020 | 451 | Jul 26, 2022 | — | — | — |
| -76.3% | Jun 27, 2011 | 1145 | Jan 13, 2016 | 1035 | Feb 25, 2020 | 2180 |
| -57.14% | Feb 24, 2010 | 209 | Dec 20, 2010 | 127 | Jun 23, 2011 | 336 |
| -50.34% | Feb 26, 2020 | 16 | Mar 18, 2020 | 55 | Jun 5, 2020 | 71 |
| -25.84% | Jul 24, 2020 | 22 | Aug 24, 2020 | 24 | Sep 28, 2020 | 46 |
| -12.4% | Jun 29, 2020 | 1 | Jun 29, 2020 | 6 | Jul 8, 2020 | 7 |
| -11.54% | Jan 8, 2010 | 9 | Jan 21, 2010 | 7 | Feb 1, 2010 | 16 |
| -9.63% | Oct 1, 2020 | 2 | Oct 2, 2020 | 3 | Oct 7, 2020 | 5 |
| -7.93% | Jun 10, 2020 | 3 | Jun 12, 2020 | 1 | Jun 15, 2020 | 4 |
| -7.69% | Jan 5, 2010 | 1 | Jan 5, 2010 | 2 | Jan 7, 2010 | 3 |
BCLIVolatility Chart
Current Brainstorm Cell Therapeutics Inc. volatility is 59.31%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.